Posted in:Legal Litigation Spotlight: The Adello Filgrastim (Neupogen®) Litigation By Rachel M. Echols May 29, 2018 Comments are off On March 8, 2018, Amgen Inc. (“Amgen”) filed suit against Adello Biologics, LLC (“Adello”) in the District of New Jersey, alleging... Read more Tagged with: Adello Biologics, Amgen, Featured, filgrastim, Legal, Neupogen®, Patent Dance, Sandoz v. Amgen http://twitter.com/share?text="[TITLE]&url=[PERMALINK]ShareEmail, Linked In, Twitter, Facebook, Google Plus
Posted in:Legal The Supreme Court’s Decision in Amgen v. Sandoz: Clear Guidance and Open Questions for Biosimilars By Jennifer P. Nock July 21, 2017 Comments are off As we previously reported here, earlier this year the Supreme Court agreed to hear its first case arising under the Biosimilars Price... Read more Tagged with: Amgen v. Sandoz, BPCIA, Legal, Litigation, Notice Requirement, Patent Dance, Sandoz v. Amgen, Supreme Court http://twitter.com/share?text="[TITLE]&url=[PERMALINK]ShareEmail, Linked In, Twitter, Facebook, Google Plus
Posted in:News Partner Nikki Gifford Presents at World Biosimilar Congress USA 2017 By C. Nichole Gifford May 26, 2017 Comments are off Partner Nikki Gifford gave a presentation entitled “Intellectual Property – Recent Developments and Implications,” at the World... Read more Tagged with: BPCIA, IPR, Litigation, Patent Dance, Sandoz v. Amgen, Supreme Court http://twitter.com/share?text="[TITLE]&url=[PERMALINK]ShareEmail, Linked In, Twitter, Facebook, Google Plus
Posted in:Legal Supreme Court Hears Oral Argument in Its First Biosimilar Case By C. Nichole Gifford April 28, 2017 Comments are off The Supreme Court heard oral arguments on Wednesday in its first biosimilar case. On a petition filed in Sandoz, Inc. v. Amgen, Inc., et... Read more Tagged with: Amgen v. Sandoz, BPCIA, Legal, Litigation, Notice Requirement, Patent Dance, Sandoz v. Amgen, Supreme Court http://twitter.com/share?text="[TITLE]&url=[PERMALINK]ShareEmail, Linked In, Twitter, Facebook, Google Plus
Posted in:Legal Briefing Completed in Supreme Court’s First Biosimilar Case By Nicole DeAbrantes April 14, 2017 Comments are off As we previously reported in this post, the Supreme Court granted certiorari in its first biosimilar case on Sandoz’s petition in Sandoz,... Read more Tagged with: Amgen v. Sandoz, BPCIA, Legal, Litigation, Notice Requirement, Patent Dance, Sandoz v. Amgen, Supreme Court http://twitter.com/share?text="[TITLE]&url=[PERMALINK]ShareEmail, Linked In, Twitter, Facebook, Google Plus
Posted in:Legal Supreme Court Grants Certiorari in First Biosimilar Case By Nicole DeAbrantes and C. Nichole Gifford January 26, 2017 Comments are off The Supreme Court has agreed to hear its first biosimilar case interpreting two provisions of the Biologics Price Competition and... Read more Tagged with: Amgen v. Sandoz, BPCIA, Legal, Litigation, Notice Requirement, Patent Dance, Sandoz v. Amgen, Supreme Court http://twitter.com/share?text="[TITLE]&url=[PERMALINK]ShareEmail, Linked In, Twitter, Facebook, Google Plus